FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Diclofenac Sodium Extended Release Tablets
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction; Rheumatology

Mylan Pharmaceuticals Inc. (New 04/04/2018)

Company Contact Information:
800-RXMYLAN (1-800-496-9526)

Presentation Posting Date Related Information
100 mg (NDC 0378-0355-01) 04/04/2018 The discontinuation of this product is a business decision and not related to product quality, safety or efficacy

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English